# Delta Neutrophil Index and Neutrophil Lymphocyte Ratio in Thyroid Malignancy

> **NCT04425512** · NA · COMPLETED · sponsor: **Kahramanmaras Sutcu Imam University** · enrollment: 333 (actual)

## Conditions studied

- Thyroid Cancer
- Thyroid Nodule
- Thyroid Diseases
- Delta Neutrophyl Index
- Immature Granulocyte Count
- Neutrophyl to Lymphocyte Ratio

## Interventions

- **DIAGNOSTIC_TEST:** Complete Blood Count

## Key facts

- **NCT ID:** NCT04425512
- **Lead sponsor:** Kahramanmaras Sutcu Imam University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-11-01
- **Primary completion:** 2019-11-01
- **Final completion:** 2019-11-01
- **Target enrollment:** 333 (ACTUAL)
- **Last updated:** 2020-06-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04425512

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04425512, "Delta Neutrophil Index and Neutrophil Lymphocyte Ratio in Thyroid Malignancy". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT04425512. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*